Study Investigates Statins and Glaucoma Risk
Understanding Glaucoma
Glaucoma is a condition characterized by increased pressure within the eye, which can adversely affect the optic nerve and may lead to blindness.
Research Overview
A recent study conducted at Brigham and Women’s Hospital, published in JAMA Ophthalmology, explored the relationship between statins—medications commonly prescribed to lower cholesterol—and the risk of developing primary open-angle glaucoma.
Study Methodology
The study tracked 136,782 individuals aged 40 and older over a 15-year period, during which 886 participants were diagnosed with primary open-angle glaucoma. Researchers gathered data through questionnaires distributed to the participants.
Key Findings
The findings revealed that individuals who used statins for five years or more experienced a 21% reduction in the likelihood of developing primary open-angle glaucoma. Conversely, the study indicated that an increase of 20 mg/dL in total serum cholesterol was associated with a 7% heightened risk of this glaucoma type. These results imply that elevated cholesterol levels may increase the risk of developing primary open-angle glaucoma while suggesting that statins could mitigate this risk.
Study Limitations and Considerations
It is important to note that a limitation of the study lies in the reliance on self-reported data from participants, which may introduce inaccuracies due to memory recall and personal interpretation of events. The study does not advocate for the use of statins as a preventive measure for individuals at high risk of glaucoma. Further clinical trials are essential to validate these findings across a broader population before any definitive recommendations regarding statin use for glaucoma prevention can be made.
References
Kang, J.H. et al 2019. Association of statin use and high serum cholesterol levels with risk of primary open-angle glaucoma. [Online]. [29 June 2019]. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/31046067
Eurekalert. 2019. Long-term statin use associated with lower glaucoma risk. [Online]. [29 June 2019]. Retrieved from https://www.eurekalert.org/pub_releases/2019-06/bawh-lsu062619.php